Arsanis, Inc. Funding Agreements
11 Contracts & Agreements
- Funding contract, dated March 23, 2017, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation) (Filed With SEC on October 20, 2017)
- Funding contract, dated July 14, 2016, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation) (Filed With SEC on October 20, 2017)
- Funding contract, dated July 20, 2015, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation) (Filed With SEC on October 20, 2017)
- Funding contract, dated July 20, 2015, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation) (Filed With SEC on October 20, 2017)
- Funding contract, dated June 9, 2014, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation) (Filed With SEC on October 20, 2017)
- Funding contract, dated April 3, 2014, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation) (Filed With SEC on October 20, 2017)
- Funding contract, dated August 6, 2013, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation) (Filed With SEC on October 20, 2017)
- Funding contract, dated March 29, 2013, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation) (Filed With SEC on October 20, 2017)
- Funding contract, dated December 5, 2012, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation) (Filed With SEC on October 20, 2017)
- Funding contract, dated July 2, 2012, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation) (Filed With SEC on October 20, 2017)
- Funding contract, dated September 20, 2011, by and between Arsanis Biosciences GmbH and sterreichische Forschungsfrderungsgesellschaft mbH (English translation) (Filed With SEC on October 20, 2017)
